- Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis 2002; 8: 181–7.
- Speert DP. Advances in Burkholderia cepacia complex. Paediatr Respir Rev 2002; 3: 230–5.
- Mahenthiralingam E, Vandamme P, Campbell ME, Henry DA, Gravelle AM, Wong LT, et al. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin Infect Dis 2001; 33: 1469–5.
- Siddiqui AH, Mulligan ME, Mahenthiralingam E, Hebden J, Brewrink J, Quiymi S, Johnson JA, Li Puma JJ, et al. An episodic outbreak of genetically related Burkholderia cepacia among non-cystic fibrosis patients at a university hospital. Infect Control Hosp Epidemiol 2001; 22: 419–22.
- Agodi A, Mahenthiralingam E, Barchitta M, Giannino V, Sciacca A, Stefani S. Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. J Clin Microbiol 2000; 39: 2891–6.
- McDowell A, Mahenthiralingam E, Moor JE, Dunbar KEA, Webb AK, Dodd ME, et al. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients. J Clin Microbiol 2001; 39: 4247–55.
- Bevivino A, Dalmastri C, Tabacchioni S, Chiarini L, Belli ML. Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility. J Clin Microbiol 2000; 2002; 40: 486–51.
- Jones AM, Dodd ME, Webb AK. Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas. Eur Respr J 2001; 17: 295–301.
- Holmes A, Nolan R, Taylor R, Finley R, Riley M, Jiang RZ, et al. An epidemic of Burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis 1999; 179: 1197–205.
- LiPuma JJ. Burkholderia cepacia epidemiology and pathogenesis: implications for infection control. Curr Opin Pul Med 1998; 4: 337–41.
- Yu WL, Wang DY, Lin CW, Tsou MF. Endemic Burkholderia cepacia bacteraemia: clinical features and antimicrobial susceptibilities of isolates. Scand J Infect Dis 1999; 31: 293–8.
- Kaitwatcharachai C, Silpapojakul K, Jitsurong S, Kalnnauwakul S. An outbreak of Burkholderia cepacia bacteraemia in haemodialysis patients: an epidemiological and molecular study. Am J Kidney Dis 2000; 36: 199–204.
- Lu DC, Chang SC, Chen YC, Luh KT, Hsieh WC. In vitro activities of antimicrobial agents, alone and in combination against Burkholderia cepacia isolated from blood. Diag Microbiol Infect Dis 1997; 28: 187–91.
- Garner JS, Javis WR, Emori TG, Horan TC, Hughes JM, et al. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128–40.
- National Committee for Clinical Standards (NCCLS). 1997. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A6. Committee for Clinical Standards, Wayne, PA., USA.
- Mahenthiralingam E, Bischof J, Byrne SK, Radomski C, Davies JE, Av-Gay Y, Vandamme P. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 2000; 38: 3165–73.
- Okazaki M, Watanabe T, Morita K, Higurashi Y, Araki K, Shukuya N, et al. Molecular epidemiological investigation using a randomly amplified polymorphic DNA assay of Burkholderia cepacia isolates from nosocomial outbreaks. J Clin Microbiol 1999; 37: 3809–14.
- Manno G, Ugolotti E, Belli ML, Fenu ML, Romano L, Cruciani M. Use of the E-test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2003; 22(1): 28–34.
- Saika T, Kobayashi I, Hasegawa M, Nishida M. Antimicrobial resistance and DNA-fingerprinting pattern of Burkholderia cepacia blood isolates. J Infect Chemother 2002; 8: 341–4.
Investigation of Burkholderia cepacia Nosocomial Outbreak with High Fatality in Patients Suffering from Diseases other than Cystic Fibrosis
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.